Skip to main content
. Author manuscript; available in PMC: 2018 Aug 3.
Published in final edited form as: Ther Innov Regul Sci. 2017 May 3;51(6):787–789. doi: 10.1177/2168479017707800

Table 1.

Types of Expanded Access INDs and Protocols Referencing Investigational Drugs for Submitted NDA and BLA.

Type of Protocol Number
Intermediate size IND 40
Intermediate size protocol 3
Single patient, emergency IND 345
Single patient, nonemergency IND 549
Treatment IND 4
Treatment protocol 3

Abbreviations: BLA, biologic licensing application; IND, investigational new drug; NDA, new drug application.